{"id":475,"date":"2014-09-02T17:30:39","date_gmt":"2014-09-02T08:30:39","guid":{"rendered":"http:\/\/urology.dept.med.gunma-u.ac.jp\/?p=475"},"modified":"2018-08-27T10:57:03","modified_gmt":"2018-08-27T01:57:03","slug":"2013%e5%b9%b4%e3%80%80%e6%a5%ad%e7%b8%be%e3%83%bb%e8%ab%96%e6%96%87","status":"publish","type":"post","link":"https:\/\/urology.dept.med.gunma-u.ac.jp\/?p=475","title":{"rendered":"2013\u5e74"},"content":{"rendered":"
    \n
  1. Arai S, Shibata Y, Nakamura Y, Kashiwagi B, Uei T, Tomaru Y, Miyashiro Y, Honma S, Hashimoto K, Sekine Y, Ito K, Sasano H and Suzuki K.\uff1a Development of prostate cancer in a patient with primary hypogonadism : intratumoural steroidogenesis in prostate cancer tissue.. Andrology; 1(1):169-174, 2013.<\/li>\n
  2. Ito K, Miyakubo M, Sekine Y, Koike H, Matsui H, Shibata Y and Suzuki K.\uff1a Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0ng\/ml range.. World J Urol; 31(2):305-311, Epub:2012\u5e748\u6708, 2013.\n
  3. \n
  4. Koike H, Matsui H, Morikawa Y, Shibata Y, Ito K and Suzuki K.\uff1a Simple method for preventing inguinal hernias after radical retropubic prostatectomy.. Prostate Int; 1(2):1-5, 2013.<\/li>\n
  5. Koike H, Morikawa Y, Matsui H, Shibata Y, Ito K and Suzuki K.\uff1a Chlormadinone acetate is effective for hot flush during androgen deprivation therapy.. Prostate Int; 1(3):1-4, 2013.<\/li>\n
  6. Shibata Y, Suzuki K, Arai S, Miyoshi Y, Umemoto S, Masumori N, Kamiya N, Ichikawa T, Kitagawa Y, Mizokami A, Sugimura Y, Nonomura N, Sakai H, Honma S and Kubata Y.\uff1a Impact of pre-treatment prostate tissue androgen content on the prediction of castration-resistant prostate cancer development in patients treated with primary androgen deprivation therapy.. Andorology; 1(3):505-511, 2013.<\/li>\n
  7. Syuto, T, Hatori M, Nomura M, Sekine Y and Suzuki K.\uff1a Chronic expanding hematoma in the retroperitoneal space:a case report. BMC Urology; 13:60, 2013.<\/li>\n
  8. Hirono M, Kobayashi Y, Tsushima T, Obara W, Shinohara N, Ito K, Eto M, Takayama T, Fujii Y, Nishikido M, Kimura G, Kishida T, Takahashi M, Miyao N, Naya Y, Abe T, Fujioka T, Ito K, Naito S and Members of the Japanese Society of Renal Cancer\uff1a Impact of clinicopathologic and operative factors on short-term and long-term survival in renal cell carcinoma with venous tumor thrombus extension:a multi-institutional retrospective study in Japan.,BMC Cancer; 34:447, 2013.<\/li>\n
  9. Magari T, Fukabori Y, Ogura H and Suzuki K.\uff1a Lower urinary tract symptoms of neurological origin in urological practice.. Clin Auton Res; 23(2):67-72, 2013.<\/li>\n
  10. Muramatsu K, Matsui H, Sekine Y, Koike H, Shibata Y, Ito K and Suzuki K.\uff1a Androgen receptor coactivator p120 subtype\u03b2 is highly expressed in prostate cancer.. Prostate Int; 1(1):10-15, 2013.<\/li>\n
  11. Akaza H, Hinotsu S, Usami M, Ogawa O, Kitamura T, Suzuki K, Tsukamoto T, Naito S, Namiki M, Hirao Y and Murai M.\uff1a Evaluation of primary androgen deprivation therapy in prosate cancer patients using the J-CAPRA risk score.. Prostate Int; 1(2):81-88, 2013.<\/li>\n
  12. Kotani K, Sekine Y, Ishikawa S, Ikpot I.Z, Suzuki K and Remaley A.T.\uff1a High-density lipoprotein and prostate cancer:An Overview.. J Epidemiol; 23(5):313-319, 2013.<\/li>\n
  13. \u4f0a\u85e4\u4e00\u4eba\uff1a proPSA\u6e2c\u5b9a\u3068\u305d\u306e\u610f\u7fa9. \u81e8\u5e8a\u691c\u67fb; 57(12):1448-1456, 2013.<\/li>\n
  14. \u4f0a\u85e4\u4e00\u4eba\uff1a proPSA\uff1a\u65b0\u898f\u816b\u760d\u30de\u30fc\u30ab\u30fc\u3068\u3057\u3066\u306e\u81e8\u5e8a\u5fdc\u7528\u3078\u306e\u671f\u5f85. \u65e5\u672c\u304c\u3093\u691c\u8a3a\u30fb\u8a3a\u65ad\u5b66\u4f1a\u8a8c; 21(2):152-155, 2013.<\/li>\n
  15. \u4f0a\u85e4\u4e00\u4eba\uff1a PSA\u691c\u8a3a\u306e\u304c\u3093\u6b7b\u6e1b\u5c11\u52b9\u679c\u306e\u6587\u732e\u7684\u691c\u8a3c\u3068\u6211\u304c\u56fd\u306e\u524d\u5411\u304d\u7814\u7a76\uff08JPSPC\uff09\u306e\u5c55\u671b. \u6ccc\u5c3f\u5668\u5916\u79d1; 26(8):1313-1316, 2013.<\/li>\n
  16. \u4f0a\u85e4\u4e00\u4eba\uff1a PIVOT\u7814\u7a76\u6210\u679c(2012\u5e74)\u306e\u6982\u8981\u3068\u89e3\u91c8. \u6ccc\u5c3f\u5668\u5916\u79d1; 26(8):1341-1343, 2013.<\/li>\n
  17. \u4f0a\u85e4\u4e00\u4eba\uff1a PSA\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u306e\u73fe\u72b6\u3068\u554f\u984c. \u81e8\u5e8a\u653e\u5c04\u7dda58\u5dfb\u5225\u518a\uff62\u524d\u7acb\u817a\u764c\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u3059\u3079\u3066-\u30ea\u30b9\u30af\u5225\u30a2\u30d7\u30ed\u30fc\u30c1\u304b\u3089\u5408\u4f75\u75c7\u5bfe\u7b56\u307e\u3067-\uff63; pp.2-10, 2013.<\/li>\n
  18. \u4f0a\u85e4\u4e00\u4eba\uff1a \u524d\u7acb\u817a\u75be\u60a3\u3068PSA\u6e2c\u5b9a\u306b\u610f\u7fa9. \u81e8\u7240\u3068\u7814\u7a76; 88(11):1356-1361, 2013.<\/li>\n
  19. \u4f0a\u85e4\u4e00\u4eba\uff1a \u2169\u7ae0. \u6ccc\u5c3f\u5668\u79d1\u816b\u760d\u5b66(\u5404\u8ad6)\u30004. \u524d\u7acb\u817a\u816b\u760d 4-1. \u524d\u7acb\u817a\u764c\u306e\u75ab\u5b66\u30fb\u691c\u8a3a. \u30d9\u30c3\u30c9\u30b5\u30a4\u30c9\u6ccc\u5c3f\u5668\u79d1\u5b66 \u6539\u8a02\u7b2c4\u7248(\u5409\u7530\u3000\u4fee\u76e3\u4fee); pp.685-692, 2013.<\/li>\n
  20. \u718a\u5742\u6587\u6210\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u6751\u4e95\u3000\u52dd\u3001\u5cf6\u5d0e\u3000\u6df3\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u5c71\u672c\u3000\u5de7\u3001\u8d64\u5009\u529f\u4e00\u90ce\uff1a \u4eba\u9593\u30c9\u30c3\u30af\u65bd\u8a2d\u306b\u304a\u3051\u308b\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u30a2\u30f3\u30b1\u30fc\u30c8\u96c6\u8a08\u5831\u544a\u3000\u2015\u5e73\u621023\u5e74\u5ea6\u8abf\u67fb\u2015. \u6ccc\u5c3f\u5668\u5916\u79d1; 26(8):1331-1335, 2013.<\/li>\n
  21. \u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u66f2\u3000\u53cb\u5f18\u3001\u72e9\u91ce\u3000\u81e8\u3001\u5bcc\u7530\u3000\u5149\u3001\u4e2d\u5d8b\u3000\u4ec1\u3001\u4f50\u85e4\u6b66\u654f\u3001\u539f\u7530\u548c\u5f66\u3001\u6238\u585a\u771f\u5f13\u3001\u77f3\u4e95\u79c0\u548c\u3001\u5f8c\u85e4\u548c\u5f18\u3001\u9ed2\u6fa4\u3000\u529f\uff1a PSA\u4f4e\u5024\u9818\u57df(20.1ng\/ml\u672a\u6e80)\u75c7\u4f8b\u306b\u304a\u3051\u308bADVIA Centaur XP(\u30b7\u30fc\u30e1\u30f3\u30b9\u30d8\u30eb\u30b9\u30b1\u30a2\u30fb\u30c0\u30a4\u30a2\u30b0\u30ce\u30b9\u30c6\u30a3\u30c3\u30af\u30b9\u682a\u5f0f\u4f1a\u793e\u88fd)\u306b\u3088\u308b\u30c8\u30fc\u30bf\u30ebPSA, \u30d5\u30ea\u30fcPSA\u306e\u81e8\u5e8a\u7684\u691c\u8a0e. \u6ccc\u5c3f\u5668\u5916\u79d1; 26(9):1415-1420, 2013.<\/li>\n
  22. \u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u66f2\u3000\u53cb\u5f18\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u72e9\u91ce\u3000\u81e8\u3001\u5bcc\u7530\u3000\u5149\u3001\u9ed2\u6fa4\u3000\u529f\u3001\u6238\u585a\u771f\u5f13\u3001\u5cf6\u7530\u548c\u5b50\u3001\u677e\u672c\u623f\u6c5f\u3001\u77f3\u4e95\u79c0\u548c\uff1a \u9ed2\u6ca2\u75c5\u9662\u5065\u5eb7\u7ba1\u7406\u30bb\u30f3\u30bf\u30fc\u4eba\u9593\u30c9\u30c3\u30af\u306b\u304a\u3051\u308b\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u53d7\u691c\u800551,077\u540d\u306e\u98df\u54c1\u30a2\u30f3\u30b1\u30fc\u30c8\u8abf\u67fb\u2015\u80a5\u6e80\u3001\u8840\u4e2dLipids\u30ec\u30d9\u30eb\u3068\u98df\u54c1\u6442\u53d6\u72b6\u6cc1\u3068\u306e\u95a2\u4fc2\u2015. \u7fa4\u99ac\u533b\u5b66; 98:5-8, 2013.<\/li>\n
  23. \u795e\u4fdd\u3000\u9032\uff1a \u524d\u7acb\u817a\u80a5\u5927\u75c7\u306b\u5bfe\u3059\u308b\u65b0\u624b\u8853\u3000\u2015120W LBO\u30ec\u30fc\u30b6\u30fc(HPS)\u306b\u3088\u308b\u524d\u7acb\u817a\u84b8\u6563\u8853(PVP)\u2015,\u7fa4\u99ac\u533b\u5b66; 98:163-167, 2013.<\/li>\n
  24. \u9234\u6728\u548c\u6d69\uff1a \u904a\u8d70\u814e\uff08\u814e\u4e0b\u5782\uff09,\u4eca\u65e5\u306e\u6cbb\u7642\u6307\u91dd2013\u5e74\u7248(\u5c71\u53e3\u3000\u5fb9\u30fb\u5317\u539f\u5149\u592b\u30fb\u798f\u4e95\u6b21\u592b\u7dcf\u7de8\u96c6); pp.983-984, 2013.<\/li>\n
  25. \u9234\u6728\u548c\u6d69\u3001\u677e\u4e95\u3000\u535a\u3001\u5927\u7af9\u4f38\u660e\uff1a \u5bb6\u65cf\u6027\u524d\u7acb\u817a\u764c\u306e\u81e8\u5e8a\u3068\u57fa\u790e,\u764c\u3068\u5316\u5b66\u7642\u6cd5; 40(2):159-163, 2013.<\/li>\n
  26. \u9234\u6728\u548c\u6d69\uff1a \u524d\u7acb\u817a\u764c\u306b\u304a\u3051\u308bCTIBL,\u764c\u3068\u9aa8(\u677e\u672c\u4fca\u592b\u30fb\u7c73\u7530\u4fca\u4e4b\u7de8); pp.325-334, 2013.<\/li>\n
  27. \u9234\u6728\u548c\u6d69\u3001\u539f\u3000\u4f73\u6d25\u884c\uff1a \u53bb\u52e2\u62b5\u6297\u6027\u524d\u7acb\u817a\u304c\u3093\u306b\u7528\u3044\u308b\u85ac,\u6ccc\u5c3f\u5668\u30b1\u30a2; 18(10):1074-1077, 2013.<\/li>\n
  28. \u9234\u6728\u548c\u6d69\u3001\u5bae\u6fa4\u6176\u884c\uff1a \u2166\u6ccc\u5c3f\u5668\u79d1\u691c\u67fb\u3068\u51e6\u7f6e\u3000\u524d\u7acb\u817a\u751f\u691c,\u65b0\u7248 \u6ccc\u5c3f\u5668\u79d1\u5468\u8853\u671f\u7ba1\u7406\u306e\u3059\u3079\u3066(\u8352\u4e95\u967d\u4e00\u7de8); pp.462-465, 2013.<\/li>\n
  29. \u9234\u6728\u548c\u6d69\u3001\u5c0f\u6c60\u79c0\u548c\uff1a \uff12\u691c\u67fb\u3000\u524d\u7acb\u817a\u751f\u691c,\u30a4\u30f3\u30d5\u30a9\u30fc\u30e0\u30c9\u30b3\u30f3\u30bb\u30f3\u30c8\u306e\u305f\u3081\u306e\u56f3\u8aac\u30b7\u30ea\u30fc\u30ba\u3000\u524d\u7acb\u817a\u304c\u3093\u6539\u8a02\u7248(\u5409\u7530\u3000\u4fee \u76e3\u4fee); pp.29-33, 2013.<\/li>\n
  30. \u7530\u6751\u82b3\u7f8e\u3001\u5927\u6728\u4e00\u6210\u3001\u897f\u4e95\u660c\u5f18\u3001\u4e95\u624b\u653f\u4fe1\u3001\u5927\u91ce\u9806\u5f18\u3001\u5927\u585a\u4fdd\u5b8f\u3001\u6a4b\u672c\u7531\u7d00\u5b50\uff1a 100\u6b73\u3067\u9670\u830e\u90e8\u5206\u5207\u9664\u8853\u3092\u65bd\u884c\u3057\u305f\u9670\u830e\u764c\u306e1\u75c7\u4f8b,\u6ccc\u5c3f\u5668\u79d1\u7d00\u8981; 59(6):381-384, 2013.<\/li>\n
  31. \u91ce\u6751\u660c\u53f2\uff1a \u7279\u96c6 \u6ccc\u5c3f\u5668\u79d1\u6551\u6025\u75be\u60a3\uff0d\u3042\u306a\u305f\u306e\u5bfe\u51e6\u306f\u9593\u9055\u3063\u3066\u3044\u307e\u305b\u3093\u304b\uff1f\u7cbe\u7d22\u637b\u8ee2, \u7cbe\u5de3\u7834\u88c2”,\u81e8\u5e8a\u6ccc\u5c3f\u5668\u79d1; 67(10):803-806, 2013.<\/li>\n
  32. \u677e\u4e95\u3000\u535a\u3001\u5927\u7af9\u4f38\u660e\u3001\u6ff1\u91ce\u9054\u4e5f\u3001\u4e2d\u7530\u8aa0\u53f8\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a \u5bb6\u65cf\u6027\u524d\u7acb\u817a\u764c\u306e\u81e8\u5e8a\u3068\u57fa\u790e. \u65e5\u672c\u814e\u6ccc\u5c3f\u5668\u75be\u60a3\u4e88\u9632\u533b\u5b66\u7814\u7a76\u4f1a\u8a8c; 21(1):32-35, 2013.<\/li>\n
  33. \u66f2\u3000\u53cb\u5f18\u3001\u5bcc\u7530\u3000\u5149\u3001\u72e9\u91ce\u3000\u81e8\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u9ed2\u6fa4\u3000\u529f\uff1a \u8179\u5727\u6027\u5c3f\u5931\u7981\u306b\u5bfe\u3059\u308bAdvantage FitTM\u306e\u4f7f\u7528\u7d4c\u9a13. \u7fa4\u99ac\u533b\u5b66; 98:105-109, 2013.<\/li>\n
  34. \u66f2\u3000\u53cb\u5f18\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u72e9\u91ce\u3000\u81e8\u3001\u5bcc\u7530\u3000\u5149\u3001\u9ed2\u6fa4\u3000\u529f\uff1a 80\u6b73\u4ee5\u4e0a\u306e\u9ad8\u9f62\u8005male LUTS\u6cbb\u7642\u306b\u5bfe\u3059\u308b\u30c7\u30e5\u30bf\u30b9\u30c6\u30ea\u30c9\u306e\u81e8\u5e8a\u7684\u691c\u8a0e\u2015\u6295\u4e0e\u75c7\u4f8b\u306e\u80cc\u666f\u306b\u7740\u76ee\u3057\u305f\u691c\u8a0e\u2015. \u65e5\u672c\u8001\u5e74\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u8a8c; 26:54, 2013.<\/li>\n
  35. \u66f2\u3000\u53cb\u5f18\uff1a \u75c7\u72b6\u304b\u3089\u307f\u308b\u75c5\u6c17\u3000\u6027\u5668\u8131(\u9aa8\u76e4\u81d3\u5668\u8131\uff09. \u5065\u5eb7\u901a\u4fe1\u5036\u697d\u90e8; 3\u6708\u53f7, 2013.<\/li>\n
  36. \u5bae\u6fa4\u6176\u884c\u3001\u91ce\u6751\u660c\u53f2\u3001\u5927\u6728\u4e00\u6210\u3001\u7530\u6751\u82b3\u7f8e\u3001\u9752\u6728\u3000\u525b\u3001\u5bae\u3000\u653f\u660e\u3001\u95a2\u53e3\u660e\u5b50\u3001\u66fd\u6211\u90e8\u967d\u5b50\u3001\u5927\u585a\u4fdd\u5b8f\uff1a Calciphylaxis\u306b\u3088\u308b\u3068\u8003\u3048\u3089\u308c\u305f\u9670\u830e\u58ca\u6b7b\u306e1\u4f8b. \u65e5\u672c\u900f\u6790\u533b\u5b66\u4f1a\u8a8c; 46(10):1027-1031, 2013.<\/li>\n
  37. \u5bae\u6fa4\u6176\u884c\u3001\u4e95\u4e0a\u96c5\u6674\u3001\u5927\u7af9\u4f38\u660e\u3001\u95a2\u539f\u54f2\u592b\uff1a \u9577\u671f\u900f\u6790\u60a3\u8005\u306b\u767a\u751f\u3057\u305f\u975e\u5916\u50b7\u6027\u814e\u5468\u56f2\u8840\u816b\u306e\uff11\u4f8b. \u81e8\u7240\u900f\u6790; 29(11):1651-1653, 2013.<\/li>\n
  38. \u7530\u4e2d\u5553\u5e79\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u85e4\u585a\u96c4\u53f8\u3001\u5cf6\u5d0e\u3000\u6df3\u3001\u5c71\u4e2d\u82f1\u58fd\uff1a \u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u7814\u7a76\u73ed(\u7530\u4e2d\u73ed)\u5e73\u621020\u5e74\u5ea6\u7d50\u679c\u5831\u544a. \u6ccc\u5c3f\u5668\u5916\u79d1; 26(8):1325-1329, 2013.<\/li>\n
  39. \u4e94\u5341\u5d50\u512a\u4ee5\u3001\u698e\u672c\u3000\u8c4a\u3001\u5185\u5800\u8ce2\u5fd7\u3001\u91d1\u4e95\u79c0\u6a39\u3001\u91d1\u4e95\u662d\u535a\u3001\u5927\u68ee\u91cd\u5b8f\u3001\u4e09\u53cb\u7f8e\u6075\u5b50\u3001\u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u9ed2\u6fa4\u3000\u529f\uff1a \u5f53\u9662\u901a\u6240\u30ea\u30cf\u306b\u304a\u3051\u308b\u3001\u904b\u52d5\u6a5f\u80fd\u8a55\u4fa1\u304b\u3089\u306e\u4e00\u8003\u5bdf. \u7fa4\u99ac\u533b\u5b66; 98:189-191, 2013.<\/li>\n
  40. \u4e0a\u539f\u7802\u77e5\u5b50\u3001\u591a\u80e1\u76f4\u4e5f\u3001\u95a2\u6839\u306e\u305e\u307f\u3001\u5927\u7af9\u798f\u5bff\u3001\u6749\u7530\u8cb4\u5b50\u3001\u66f2\u3000\u53cb\u5f18\u3001\u72e9\u91ce\u3000\u81e8\u3001\u5bcc\u7530\u3000\u5149\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u9ed2\u6fa4\u3000\u529f\uff1a \u5f53\u9662\u306e\u900f\u6790\u60a3\u8005\u306b\u304a\u3051\u308b\u8179\u90e8\u8d85\u97f3\u6ce2\u691c\u67fb\u306e\u691c\u8a0e. \u7fa4\u99ac\u533b\u5b66; 98:193-196, 2013.<\/li>\n
  41. \u5927\u68ee\u91cd\u5b8f\u3001\u4e2d\u5cf6\u307e\u3086\u3001\u677e\u8c37\u96c5\u751f\u3001\u9ed2\u6fa4\u3000\u529f\uff1a \u8133\u30c9\u30c3\u30af\u30ea\u30d4\u30fc\u30bf\u30fc\u304b\u3089\u5f97\u3089\u308c\u305f\u53d7\u8a3a\u9593\u9694\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e. \u7fa4\u99ac\u533b\u5b66; 98:137-140, 2013.<\/li>\n
  42. \u5c0f\u95a2\u967d\u5b50\u3001\u4e95\u51fa\u3000\u5065\u3001\u65b0\u4e95\u5f18\u6075\u3001\u95a2\u6839\u771f\u7d00\u3001\u65e5\u8d8a\u6075\u7f8e\u5b50\u3001\u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u9ed2\u6fa4\u3000\u529f\uff1a \u524d\u7acb\u817a\u91dd\u751f\u691c\u306b\u95a2\u3059\u308b\u8853\u524d\u304a\u3088\u3073\u8853\u5f8c\u306e\u30a2\u30f3\u30b1\u30fc\u30c8\u8abf\u67fb\u7d50\u679c\u306b\u3064\u3044\u3066\u306e\u5206\u6790\u2015\u7b2c\uff14\u5831\u2015\u3000\u2015\u5e74\u9f62\u968e\u5c64\u5225\u306e\u5206\u6790\u30fb\u691c\u8a0e\u2015. \u7fa4\u99ac\u533b\u5b66; 98:103-104, 2013.<\/li>\n
  43. \u5317\u722a\u9759\u9999\u3001\u4f0a\u85e4\u73b2\u5b50\u3001\u898b\u7530\u3000\u5c0a\u3001\u8302\u6728\u4fca\u4e00\u3001\u6c60\u7530\u5f13\u6075\u3001\u5927\u7af9\u304b\u304a\u308a\u3001\u5c71\u5d0e\u7f8e\u4ee3\u5b50\u3001\u6b66\u4e95\u6643\u53f8\u3001\u5c71\u4e0b\u9054\u77e2\u3001\u9ed2\u6fa4\u3000\u529f\uff1a \u5f53\u9662\u306b\u304a\u3051\u308bCT\u30b3\u30ed\u30ce\u30b0\u30e9\u30d5\u30a3\u306e\u73fe\u72b6\u3068\u4eca\u5f8c\u306e\u8ab2\u984c. \u7fa4\u99ac\u533b\u5b66; 98:33-36, 2013.<\/li>\n
  44. \u5009\u6797\u3000\u5f69\u3001\u5409\u539f\u5c0a\u6a39\u3001\u52a0\u702c\u5609\u660e\u3001\u9ed2\u6fa4\u3000\u529f\uff1a \u30a8\u30a4\u30b8\u30f3\u30b0\u30b1\u30a2\u30b5\u30ed\u30f3\u30fb\u30d5\u30a3\u30aa\u30fc\u30ec\u306b\u304a\u3051\u308b\u7406\u5b66\u7642\u6cd5\u58eb\u306b\u3088\u308b\u65bd\u8853\u306e\u5fc5\u8981\u6027\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e. \u7fa4\u99ac\u533b\u5b66; 98:203-206, 2013.<\/li>\n
  45. \u6817\u539f\u7167\u660c\u3001\u85e4\u4e95\u5b5d\u5c1a\u3001\u7530\u53e3\u6b63\u6bc5\u3001\u5c0f\u6797\u52c7\u6cbb\u3001\u9ed2\u6fa4\u3000\u529f\uff1a \u4e73\u764c\u306b\u5bfe\u3059\u308bCT\u30ea\u30f3\u30d5\u30a9\u30b0\u30e9\u30d5\u30a3\u3092\u30ac\u30a4\u30c9\u306b\u3057\u305f\u5185\u8996\u93e1\u88dc\u52a9\u4e0b\u30bb\u30f3\u30c1\u30cd\u30eb\u30ea\u30f3\u30d1\u7bc0\u751f\u691c. \u7fa4\u99ac\u533b\u5b66; 98:25-31, 2013.<\/li>\n
  46. \u6749\u7530\u8cb4\u5b50\u3001\u539f\u7530\u548c\u5f66\u3001\u4f50\u85e4\u6b66\u654f\u3001\u5409\u539f\u5c0a\u6a39\u3001\u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u677e\u672c\u623f\u6c5f\u3001\u9ed2\u6fa4\u7531\u7f8e\u5b50\u3001\u9ed2\u6fa4\u3000\u529f\uff1a \u524d\u7acb\u817a\u304c\u3093\u306b\u95a2\u3059\u308b\u30a2\u30f3\u30b1\u30fc\u30c8\u8abf\u67fb\u5831\u544a. \u7fa4\u99ac\u533b\u5b66; 98:197-202, 2013.<\/li>\n
  47. \u9ad8\u6a4b\u7d00\u88d5\u3001\u9732\u6728\u5bff\u5b50\u3001\u4e0a\u91ce\u54f2\u54c9\u3001\u585a\u8d8a\u548c\u5b50\u3001\u718a\u5742\u6587\u6210\u3001\u9ed2\u6fa4\u3000\u529f\uff1a \u30b5\u30fc\u30d3\u30b9\u4ed8\u304d\u9ad8\u9f62\u8005\u5411\u3051\u4f4f\u5b85\u306b\u304a\u3044\u3066\u85ac\u5264\u306e\u526f\u4f5c\u7528\u3092\u767a\u898b\u3057\u305f\uff11\u75c7\u4f8b. \u7fa4\u99ac\u533b\u5b66; 98:111-112, 2013.<\/li>\n
  48. \u897f\u5c71\u3000\u6075\u3001\u5009\u7530\u3000\u552f\u3001\u6e05\u6c34\u3000\u78a7\u3001\u5c0f\u677f\u6a4b\u53cb\u91cc\u3001\u6afb\u4e95\u667a\u5b50\u3001\u6238\u585a\u771f\u5f13\u3001\u5cf6\u7530\u548c\u5b50\u3001\u677e\u672c\u623f\u6c5f\u3001\u77f3\u4e95\u79c0\u548c\u3001\u5f8c\u85e4\u548c\u5f18\u3001\u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u9ed2\u6fa4\u3000\u529f\uff1a \u5f53\u30bb\u30f3\u30bf\u30fc\u306e\u7279\u5b9a\u4fdd\u5065\u6307\u5c0e\u306e\u52b9\u679c\u3068\u8ab2\u984c. \u7fa4\u99ac\u533b\u5b66; 98:13-16, 2013.<\/li>\n
  49. \u65e9\u6fa4\u88d5\u7f8e\u5b50\u3001\u661f\u91ce\u8cb4\u7f8e\u6c5f\u3001\u4e0b\u6751\u7d00\u5b50\u3001\u4e0a\u539f\u7802\u77e5\u5b50\u3001\u9ed2\u7530\u6b63\u5df3\u3001\u690d\u7530\u660c\u7537\u3001\u5927\u7af9\u798f\u5bff\u3001\u66f2\u3000\u53cb\u5f18\u3001\u9ed2\u6fa4\u3000\u529f\uff1a \u900f\u6790\u60a3\u8005\u3068\u975e\u900f\u6790\u60a3\u8005\u306e\u30d5\u30a9\u30eb\u30e0\u691c\u67fb\u7d50\u679c\u306b\u304a\u3051\u308b\u6bd4\u8f03. \u7fa4\u99ac\u533b\u5b66; 98:119-128, 2013.<\/li>\n
  50. \u6df1\u8c9d\u9686\u5fd7\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u5c0f\u5ddd\u826f\u96c4\u3001\u8d64\u5009\u529f\u4e00\u90ce\u3001\u6728\u6751\u3000\u525b\u3001\u8fd1\u85e4\u5e78\u5c0b\u3001\u9ed2\u6fa4\u3000\u529f\u3001\u5c0f\u6797\u5e79\u7537\u3001\u53e4\u4f5c\u3000\u671b\u3001\u9580\u9593\u54f2\u96c4\u3001\u795e\u51fa\u3000\u4eae\u3001\u5824\u3000\u662d\u4e8c\u3001Wendy Poage\u3001Nelson Stone\uff1a \u7c73\u56fd\u306b\u304a\u3051\u308b\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u5553\u767a\u6d3b\u52d5\u3068\u6211\u304c\u56fd\u306e\u5553\u767a\u6d3b\u52d5\uff08\u30d6\u30eb\u30fc\u30af\u30ed\u30fc\u30d0\u30fc\u30fb\u30ad\u30e3\u30f3\u30da\u30fc\u30f3\uff09. \u6ccc\u5c3f\u5668\u5916\u79d1; 26(8):1311-1312, 2013.<\/li>\n
  51. \u8302\u6728\u4fca\u4e00\u3001\u696b\u3000\u9756\u3001\u52dd\u53c8\u5eb7\u53cb\u3001\u898b\u7530\u3000\u5c0a\u3001\u4f0a\u85e4\u73b2\u5b50\u3001\u6c60\u7530\u5f13\u6075\u3001\u5927\u7af9\u304b\u304a\u308a\u3001\u5800\u8d8a\u7f8e\u4ee3\u5b50\u3001\u5317\u722a\u9759\u9999\u3001\u6b66\u4e95\u6643\u53f8\u3001\u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u66f2\u3000\u53cb\u5f18\u3001\u72e9\u91ce\u3000\u81e8\u3001\u5bcc\u7530\u3000\u5149\u3001\u9ed2\u6fa4\u3000\u529f\uff1a PRESS\u6cd5\u306b\u3088\u308b\u524d\u7acb\u817a\u30de\u30eb\u30c1\u30dc\u30af\u30bb\u30eb\u30d7\u30ed\u30c8\u30f3MRS\u30d5\u30a1\u30f3\u30c8\u30e0\u3092\u7528\u3044\u305f\u6e2c\u5b9a\u6642\u9593\u77ed\u7e2e\u306b\u95a2\u3059\u308b\u691c\u8a0e. \u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u96d1\u8a8c; 33(2):76-84, 2013.<\/li>\n
  52. \u8302\u6728\u4fca\u4e00\u3001\u898b\u7530\u3000\u5c0a\u3001\u4f0a\u85e4\u73b2\u5b50\u3001\u6c60\u7530\u5f13\u6075\u3001\u5927\u7af9\u304b\u304a\u308a\u3001\u5c71\u5d0e\u7f8e\u4ee3\u5b50\u3001\u5317\u722a\u9759\u9999\u3001\u6b66\u4e95\u6643\u53f8\u3001\u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u696b\u3000\u9756\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u66f2\u3000\u53cb\u5f18\u3001\u72e9\u91ce\u3000\u81e8\u3001\u5bcc\u7530\u3000\u5149\u3001\u9ed2\u6fa4\u3000\u529f\uff1a \u524d\u7acb\u817a\u30d7\u30ed\u30c8\u30f3MR\u30b9\u30da\u30af\u30c8\u30ed\u30b9\u30b3\u30d4\u30fc\u2015\u4e0d\u6210\u529f\u306e\u539f\u56e0\u306b\u95a2\u3059\u308b\u691c\u8a0e\u2015. \u7fa4\u99ac\u533b\u5b66; 98:175-181, 2013.<\/li>\n
  53. \u77e2\u5cf6\u7fa9\u662d\u3001\u5f8c\u85e4\u548c\u5f18\u3001\u77f3\u4e95\u79c0\u548c\u3001\u6749\u7530\u8cb4\u5b50\u3001\u4f50\u85e4\u6b66\u654f\u3001\u6238\u585a\u771f\u5f13\u3001\u9ad8\u6a4b\u54f2\u4e8c\u3001\u9ed2\u6fa4\u3000\u529f\uff1a \u5065\u8a3a\u4f8b\u306b\u304a\u3051\u308bNonalcoholic fatty liver disease\u3068\u8840\u6e05\u03b3-glutamyltransferase\u306e\u95a2\u4fc2\u306b\u3064\u3044\u3066. \u4eba\u9593\u30c9\u30c3\u30af; 27(5):837-842, 2013.<\/li>\n
  54. \u6a2a\u5c71\u3000\u52c7\u3001\u50b3\u7530\u548c\u6075\u3001\u9ad8\u6a4b\u96c4\u4e00\u3001\u9f4b\u85e4\u5fd7\u4e43\u3001\u95a2\u3000\u96c5\u5f66\u3001\u9ad8\u6a4b\u7406\u6075\u3001\u9ed2\u6fa4\u3000\u529f\uff1a \u30e1\u30c7\u30a3\u30ab\u30eb\u30d5\u30a3\u30c3\u30c8\u30cd\u30b9\u306b\u304a\u3051\u308b\u5165\u4f1a\u6642\u6804\u990a\u30ab\u30a6\u30f3\u30bb\u30ea\u30f3\u30b0\u306e\u4f53\u91cd\u30fb\u4f53\u8102\u80aa\u91cf\u6e1b\u5c11\u3078\u306e\u52b9\u679c\u306e\u691c\u8a0e. \u7fa4\u99ac\u533b\u5b66; 98:9-12, 2013.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    Arai S, Shibata Y, Nakamura Y, Kashiwagi B, Uei T, Tomaru Y, Miyashiro Y, Honma S, Hashimoto K, Sekine Y, Ito […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-475","post","type-post","status-publish","format-standard","hentry","category-achievements"],"_links":{"self":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/475","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=475"}],"version-history":[{"count":6,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/475\/revisions"}],"predecessor-version":[{"id":1310,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/475\/revisions\/1310"}],"wp:attachment":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=475"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=475"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}